Nov 06, 2023
AVT has participated in CPhI Barcelona 2023 at Barcelona, Spain from 24 - 26 October.Thanks for meeting us and having fruitful discussions about AVT's injectable pharmaceutical excipients for biol...
Oct 20, 2023
The COVID-19 pandemic has triggered an unprecedented mobilization of resources to find vaccines and therapeutics to treat and prevent infection with SARS-CoV-2. MRNA technology was quickly adopted in ...
Oct 10, 2023
In the previous two issues, we shared relevant studies on the use of D(+)-trehalose dihydrate for cryopreservation of human-derived oligodendrocyte precursor cells (OPCs) and adipose-derived stem cell...
Sep 30, 2023
D(+)-trehalose dihydrate is a stable non-reducing disaccharide. It can form a protective film on the surface of cells under various environmental stresses such as extreme heat, cold, drought, effectiv...
Sep 25, 2023
In the previous issue, we shared the study on the use of D(+)-trehalose dihydrate in cryopreservation of human oligodendrocyte precursor cells (OPCs). The study concluded that the cryopreservation med...
Sep 11, 2023
In the first three issues, we shared the studies of D(+)-trehalose dihydrate in the cryoprotection of human oligodendrocyte precursor cells (OPCs), adipose-derived stem cells (ADSCs), mouse testicular...
Aug 17, 2023
Haikou City, Hainan Province On 30 July 2023, with the support of the People's Government of Hainan Province, the first China Capital of Medical Aesthetic Industry Summit Forum & Expo (CMAIE) ...
Jul 13, 2023
AVT has participated in CPhI China 2023 at Shanghai, China from 19 - 21 June. Our booth no. is E4D22.Thanks for meeting us and having fruitful discussions about AVT's injectable pharmaceutical exc...
